Dr. Isabell Ge

Ge, Isabell, Berner, Kai, Klanke, Christina, Wagner, Christin, Mihzintu, Sarah, Boeglé, Marion, Fasanella, Veronica, Urech, Corinne, Cassidy, Monica, Felder, Chiara, Beiglböck, Astrid, Montavon, Céline, Vetter, Rona, Steinle, Bettina, Weber, Walter Paul, Heinzelmann-Schwarz, Viola, & Kurzeder, Christian. (2026). Integrative Medizin bei Brust- und gynäkologischen Krebserkrankungen – am Beispiel des Universitätsspitals Basel. Onkologiepflege, 2026(1), 10–12.

Ge, Isabell, Gaignard, Marie-Estelle, Kohler, Sara, Reusch, Julia, Strasser, Florian, & Templeton, Arnoud J. (2025). Evidenz, Forschungsmethodik und Qualitätskriterien in der Integrativen Onkologie: Grundlagen, Konsens und Perspektiven. Therapeutische Umschau. Revue therapeutique, 82(5), 157–162. https://doi.org/10.23785/TU.2025.05.003

Kalbermatten,Natalie, Berna,Chantal, Bordry,Natacha, Gaignard,Marie-Estelle, Ge,Isabell, Kohler,Sara, Nothhelfer,Tilly, Strasser,Florian, Usluoglu,Nurgül, Witt,Claudia M., & Wolf,Ursula. (2025). Gemeinsamkeiten und Kerndisziplinen der Integrativen Onkologie. Therapeutische Umschau. Revue therapeutique, 82(5), 144–162. https://doi.org/10.23785/TU.2025.05.002

Asberger, Jasmin, Ge, Isabell, Schmidt, Benjamin, Jäger, Markus, Weiss, Daniela, Berner, Kai, Erbes, Thalia, Juhasz‑Böss, Ingolf, & Mayer, Sebastian. (2025). Long non‑coding RNA signatures in breast cancer: Properties as biomarkers? [Journal-article]. Experimental and Therapeutic Medicine, 29(3). https://doi.org/10.3892/etm.2025.12804

Ge, Isabell, Berner, Kai, Mathis, Marlene, Hensgen, Catherine, Mayer, Sebastian, Erbes, Thalia, Juhasz-Böss, Ingolf, & Asberger, Jasmin. (2024). Real-World Data Analysis of CDK4/6 Inhibitor Therapy—A Patient-Centric Single Center Study. Cancers, 16(9). https://doi.org/10.3390/cancers16091760

Ge, Isabell, Meschede, Julia, Juhasz-Boess, Ingolf, Kunze, Mirjam, & Markfeld-Erol, Filiz. (2024). Does structured obstetric management play a role in the delivery mode and neonatal outcome of twin pregnancies? Archives of Gynecology and Obstetrics, 309(4), 1441–1452. https://doi.org/10.1007/s00404-023-07040-6

Asberger, Jasmin, Berner, Kai, Bicker, Anna, Metz, Marius, Jäger, Markus, Weiß, Daniela, Kreutz, Clemens, Juhasz-Böss, Ingolf, Mayer, Sebastian, Ge, Isabell, & Erbes, Thalia. (2023). In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer. Biomedicines, 11(10). https://doi.org/10.3390/biomedicines11102705

Ge, Isabell, Geißler, Carmen, Geffroy, Alexandra, Juhasz-Böss, Ingolf, Wiehle, Philipp, & Asberger, Jasmin. (2023). Treatment of Cesarean Scar and Cervical Pregnancies Using the Ovum Aspiration Set for Intrachorial Methotrexate Injection as a Conservative, Fertility-Preserving Procedure. Medicina (Lithuania), 59(4). https://doi.org/10.3390/medicina59040761

Juhasz-Böss, I., Schleiß, T., Koch, M., Schulmeyer, C., Fleisch, M., Hepp, P., Medl, M., Ge, I., & Papathemelis, T. (2023). Vorstufen und bösartige Veränderungen am Genital. In Gynäkologie und Geburtshilfe (pp. 227–282). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-59164-2_13

Ge, Isabell, Erbes, Thalia, & Juhasz-Böss, Ingolf. (2022). Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature. Archives of Gynecology and Obstetrics, 306(4), 943–957. https://doi.org/10.1007/s00404-021-06352-9

Hoefflin R, Lazarou A, Hess ME, Reiser M, Wehrle J, Metzger P, Frey AV, Becker H, Aumann K, Berner K, Boeker M, Buettner N, Dierks C, Duque-Afonso J, Eisenblaetter M, Erbes T, Fritsch R, Ge IX, Geißler AL, et al. (2021). Transitioning the molecular tumor board from proof of concept to clinical routine: A german single-center analysis. Cancers, 13(5), 1–18. https://doi.org/10.3390/cancers13051151

HIRSCHFELD, M., GE, I., RÜCKER, G., WALDSCHMIDT, J., MAYER, S., JÄaGER, M., VOIGT, M., KAMMERER, B., NÖTHLING, C., BERNER, K., WEISS, D., ASBERGER, J., & ERBES, T. (2020). Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro. Molecular Medicine Reports, 22(5), 4048–4060. https://doi.org/10.3892/mmr.2020.11466

Ge, I., Geißler, C., Prömpeler, H.-J., Juhasz-Böss, I., & Wiehle, P. (2020, October 7). Intrachoriale und systemische Methotrexat (MTX)-Applikation bei Zervix- und Sectionarbengravidität als konservativer, fertilitätserhaltender Behandlungsansatz [Proceedings-article]. In Geburtshilfe und Frauenheilkunde. Georg Thieme Verlag. https://doi.org/10.1055/s-0040-1718072

Geißler, C., Ge, I., Hess, M., Metzger, P., Bronsert, P., Lassmann, S., Börries, M., Juhasz-Böss, I., Illert, A.-L., & Bossart, M. (2020, October 1). Personalisierte Therapie des therapieresistenten Ovarialkarzinoms einer jungen Patientin [Proceedings-article]. https://doi.org/10.1055/s-0040-1718269

Wolf, M., Berner, K., Ge, I., Juhasz-Böss, I., & Erbes, T. (2020, July 1). Mamma fistulans – Eine Blickdiagnose [Proceedings-article]. https://doi.org/10.1055/s-0040-1714641

Hoefflin R, Geißler AL, Fritsch R, Claus R, Wehrle J, Metzger P, Reiser M, Mehmed L, Fauth L, Heiland DH, Erbes T, Stock F, Csanadi A, Miething C, Weddeling B, Meiss F, von Bubnoff D, Dierks C, Ge I, et al. (2018). Personalized clinical decision making through implementation of a molecular tumor board: A German single-center experience. JCO Precision Oncology, 2(2), 1–16. https://doi.org/10.1200/po.18.00105

Ge, Isabell, Saliba, Rima M., Maadani, Farzaneh, Popat, Uday R., Qazilbash, Muzaffar H., Ravi Pingali, Sai, Shah, Nina, Ahmed, Sairah, Bashir, Qaiser, Nieto, Yago, Champlin, Richard E., & Hosing, Chitra M. (2017). Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma. Transfusion, 57(4), 1052–1057. https://doi.org/10.1111/trf.14016

Gaballa S, Ge I, El Fakih R, Brammer JE, Kongtim P, Tomuleasa C, Wang SA, Lee D, Petropoulos D, Cao K, Rondon G, Chen J, Hammerstrom A, Lombardi L, Alatrash G, Korbling M, Oran B, Kebriaei P, Ahmed S, et al. (2016). Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Cancer, 122(21), 3316–3326. https://doi.org/10.1002/cncr.30180

Ge, Isabell, Rudolph, Anja, Johnson, Theron, Jaskulski, Stefanie, Shivappa, Nitin, Hébert, James R., Kaaks, Rudolf, Flesch-Janys, Dieter, Thoene, Kathrin, & Chang-Claude, Jenny. (2016). Association of circulating inflammatory biomarkers and dietary inflammation potential with postmenopausal breast cancer prognosis. (Journal-article No. 15_suppl). Journal of Clinical Oncology, 34(15_suppl), Article 15_suppl. https://doi.org/10.1200/jco.2016.34.15_suppl.1566

Ge, Isabell, Rudolph, Anja, Shivappa, Nitin, Flesch-Janys, Dieter, Hébert, James R., & Chang-Claude, Jenny. (2015). Dietary inflammation potential and postmenopausal breast cancer risk in a German case-control study. Breast, 24(4), 491–496. https://doi.org/10.1016/j.breast.2015.04.012

Cai, Fengfeng, Ge, Isabell, Wang, Minghong, Biskup, Ewelina, Lin, Xiaoyan, & Zhong, Xiaoyan. (2014). Pyrosequencing analysis of BRCA1 methylation level in breast cancer cells. Tumor Biology, 35(4), 3839–3844. https://doi.org/10.1007/s13277-013-1508-2

Zheng LH, Cai FF, Ge I, Biskup E, & Cheng ZP. (2014). Stromal fibroblast activation and their potential association with uterine fibroids. Oncology Letters, 8(2), 479–486. https://doi.org/10.3892/ol.2014.2225